When Belén Garijo, M.D., Ph.D., left the top job at Germany's Merck KGaA to head over to Sanofi, she...
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
When Belén Garijo, M.D., Ph.D., left the top job at Germany's Merck KGaA to head over to Sanofi, she was inheriting a company in need of course correction.
Author: Fierce Biotech
Read Original Article